Hindustan Unilever Limited's Board of Directors approved significant strategic portfolio decisions during their meeting on February 12, 2026, including the acquisition of remaining stake in Zywie Ventures and divestment of Nutritionalab shareholding, alongside Q3FY26 financial results. The company has also made its quarterly earnings call recording available online.

Strategic Portfolio Transactions Approved

The Board approved two major strategic decisions during their February 12, 2026 meeting. The company will acquire the remaining 49% stake in Zywie Ventures Private Limited for a cash consideration of ₹824 crores, making it a wholly owned subsidiary. Additionally, the Board approved the divestment of the company's entire 19.8% shareholding in Nutritionalab Private Limited to USV Private Limited for ₹307 crores.

Zywie Ventures (OZiva) Performance and Rationale

Zywie Ventures, operating under the OZiva brand, has demonstrated exceptional growth since HUL's initial 51% acquisition in January 2023. The company scaled to approximately ₹480 crores in 2025, achieving around 130% CAGR over the last two years. The Health & Wellbeing business focuses on vitamins, minerals, supplements, beauty and personal care products.

Q3FY26 Financial Performance

The company delivered robust operational performance during Q3FY26 with continuing operations showing steady growth across key metrics. Total sales from continuing operations reached ₹16,235 crores compared to ₹15,322 crores in the corresponding quarter.

Ice Cream Business Demerger Impact

The company successfully completed the demerger of its ice cream business to Kwality Wall's (India) Limited effective December 1, 2025. The transaction resulted in an exceptional gain of ₹4,611 crores, contributing to the reported profit after tax of ₹6,603 crores for the quarter, representing 121% growth.

Earnings Call Recording Available

Following the company's letter dated February 4, 2026, and in compliance with Regulation 30(6) of SEBI Listing Obligations, Hindustan Unilever has made the audio/video recording of its Q3FY26 earnings conference call available on the company website. Company Secretary & Compliance Officer Radhika Shah confirmed the availability of the recording on February 13, 2026.

CEO and Managing Director Priya Nair commented that Health & Wellbeing represents an important growth vector driven by rising consumer interest in everyday wellness. The full ownership of OZiva enables the company to unlock the next phase of growth while reflecting the strategy of fewer, bigger bets leveraging HUL's strengths in science, distribution and market development.

Hindustan Unilever has received a substantial acquisition disclosure from Life Insurance Corporation of India (LIC), India's largest life insurer, under SEBI's Substantial Acquisition of Shares and Takeover Regulations, 2011. The disclosure, dated January 19, 2026, reveals LIC's increased investment in the FMCG major through systematic open market purchases.

Shareholding Details

LIC's strategic acquisition has resulted in a notable increase in its stake in Hindustan Unilever. The insurance corporation has crossed the significant 5% threshold, triggering mandatory regulatory disclosure requirements.

Transaction Overview

The acquisition involved the purchase of 4,71,90,691 shares, representing 2.01% of Hindustan Unilever's total voting capital. LIC executed these transactions exclusively through open market purchases, demonstrating a systematic approach to building its position in the consumer goods company.

Key Transaction Details:

• Acquisition Period: March 23, 2022 to January 16, 2026
• Mode of Purchase: Open market transactions
• Stock Exchanges: NSE and BSE
• Promoter Status: LIC does not belong to the promoter group

Regulatory Compliance

LIC has fulfilled its regulatory obligations by submitting the required disclosure format under Regulation 29(2) of SEBI regulations. The disclosure was simultaneously sent to both major stock exchanges where Hindustan Unilever shares are listed - NSE and BSE.

The company's total equity share capital remained unchanged at ₹234.96 crores throughout the acquisition period, indicating that LIC's purchases were from existing shareholders in the secondary market rather than through any fresh equity issuance.

Investment Significance

This substantial acquisition reflects LIC's investment strategy and confidence in Hindustan Unilever's long-term prospects. The systematic nature of the purchases, spread over nearly four years, suggests a deliberate portfolio building exercise rather than opportunistic trading. LIC's increased stake positions it as a significant institutional investor in one of India's most established consumer goods companies.